NSC |
Compound |
Enrichment |
Correlation |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.0267520285931239 |
0.18175898 |
NSC 133118 |
2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) |
0.0267520285931239 |
-0.32352898 |
NSC 166199 |
Phosphinic amide, P,P-bis(1-aziridinyl)-N-tricyclo[3.3.1.1(3.7)]dec-1-yl- (9CI) |
0.0267520285931239 |
0.1418005 |
NSC 168516 |
Benzene, 1,1'-(1,2-ethanediyl)bis[2,5-dimethoxy- |
0.0267520285931239 |
-0.01653169 |
NSC 295499 |
Camptothecin Derivative |
0.0267520285931239 |
0.41379618 |
NSC 330507 |
Tanespimycin |
0.0267520285931239 |
0.10995758 |
NSC 374980 |
Acetamide, N-[2,3-bis(acetyloxy)-5,6,7,9-tetrahydro-1-methoxy-10-(methylthio)-9-oxobenzo[a]heptalen-7-yl]-, (S)- |
0.0267520285931239 |
0.32230302 |
NSC 649826 |
Null |
0.0267520285931239 |
0.18836191 |
NSC 650935 |
3,8-Dimethyl-1,2-naphthoquinone |
0.0267520285931239 |
-0.10930147 |
NSC 655905 |
ANTINEOPLASTIC-655905 |
0.0267520285931239 |
0.037867506 |